{"id":"https://openalex.org/W2432654785","doi":null,"title":"Review of phase II trials of Taxol (paclitaxel) in patients with advanced ovarian cancer.","display_name":"Review of phase II trials of Taxol (paclitaxel) in patients with advanced ovarian cancer.","publication_year":1994,"publication_date":"1994-01-01","ids":{"openalex":"https://openalex.org/W2432654785","mag":"2432654785","pmid":"https://pubmed.ncbi.nlm.nih.gov/7865430"},"language":"en","primary_location":{"id":"pmid:7865430","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7865430","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of oncology : official journal of the European Society for Medical Oncology","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5023965046","display_name":"Einzig Ai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129975664","display_name":"Albert Einstein College of Medicine","ror":"https://ror.org/05cf8a891","country_code":"US","type":"education","lineage":["https://openalex.org/I129975664","https://openalex.org/I4210112371"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"A I Einzig","raw_affiliation_strings":["Albert Einstein Cancer Center, Bronx, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Albert Einstein Cancer Center, Bronx, New York","institution_ids":["https://openalex.org/I129975664"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5023965046"],"corresponding_institution_ids":["https://openalex.org/I129975664"],"apc_list":null,"apc_paid":null,"fwci":0.3999,"has_fulltext":false,"cited_by_count":15,"citation_normalized_percentile":{"value":0.67812669,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"5 Suppl 6","issue":null,"first_page":"S29","last_page":"32"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":1.0},{"id":"https://openalex.org/keywords/advanced-ovarian-cancer","display_name":"advanced ovarian cancer","score":0.9980000257492065},{"id":"https://openalex.org/keywords/cisplatin-refractory-disease","display_name":"cisplatin-refractory disease","score":0.8899999856948853},{"id":"https://openalex.org/keywords/chemotherapy-efficacy","display_name":"chemotherapy efficacy","score":0.46700000762939453},{"id":"https://openalex.org/keywords/overall-response-rate","display_name":"overall response rate","score":0.7319999933242798},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.609000027179718},{"id":"https://openalex.org/keywords/time-to-progression","display_name":"time to progression","score":0.7979999780654907}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.93747878074646},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.6614279747009277},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.6236587166786194},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.6131464838981628},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6123021841049194},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5275005102157593},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5269359350204468},{"id":"https://openalex.org/C2780435969","wikidata":"https://www.wikidata.org/wiki/Q5625186","display_name":"Gynecologic oncology","level":2,"score":0.5161606073379517},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.4502319097518921},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4362308084964752},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4243556261062622},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.41891559958457947},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.35941532254219055},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D002945","descriptor_name":"Cisplatin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004351","descriptor_name":"Drug Resistance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007262","descriptor_name":"Infusions, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D011292","descriptor_name":"Premedication","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015996","descriptor_name":"Survival Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016879","descriptor_name":"Salvage Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D017322","descriptor_name":"Clinical Trials, Phase II as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:7865430","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7865430","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of oncology : official journal of the European Society for Medical Oncology","raw_type":"Journal Article"},{"id":"mag:2432654785","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7865430","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2052332322","https://openalex.org/W108614791","https://openalex.org/W1970725174","https://openalex.org/W2141258764","https://openalex.org/W2053771790","https://openalex.org/W2035152690","https://openalex.org/W2059761343","https://openalex.org/W1880772556","https://openalex.org/W2253428544","https://openalex.org/W2017076579"],"abstract_inverted_index":{"The":[0,151],"efficacy":[1],"and":[2,22,57,143,214,249],"safety":[3],"of":[4,9,78,121,158,184,186,234],"paclitaxel":[5,103,159],"in":[6,16,37,94,168],"the":[7,25,79,98,156,219],"treatment":[8],"advanced":[10],"ovarian":[11,72],"cancer":[12,73],"has":[13],"been":[14,82],"assessed":[15],"several":[17],"phase":[18,34],"II":[19,35],"trials.":[20],"McGuire":[21],"associates":[23],"at":[24,97],"Johns":[26],"Hopkins":[27],"Oncology":[28,153],"Cancer":[29,101,221],"reported":[30],"results":[31],"from":[32],"a":[33,41,95,109,163],"trial":[36],"which":[38],"paclitaxel-administered":[39],"as":[40,108,162],"24-hour":[42,110,165],"intravenous":[43],"(i.v.)":[44],"infusion":[45,112],"with":[46,71,190,242],"premedication":[47],"to":[48,84,105,132,254],"avoid":[49],"acute":[50],"hypersensitivity":[51],"reactions-yielded":[52],"one":[53],"complete":[54],"response":[55,63,119,241],"(CR)":[56],"11":[58],"partial":[59],"responses":[60],"(PRs)":[61],"(overall":[62],"rate,":[64],"30%)":[65],"among":[66,173],"40":[67],"previously":[68],"treated":[69],"patients":[70,80,90,129,189,200,236,258],"evaluable":[74,89,170,239],"for":[75,138,146,240,256],"response;":[76],"25":[77],"had":[81,212,216],"refractory":[83],"cisplatin":[85,134,209],"therapy.":[86,135],"Among":[87,198],"30":[88],"who":[91],"took":[92],"part":[93],"study":[96],"Albert":[99],"Einstein":[100],"Center,":[102],"(180":[104],"250":[106,264],"mg/m2":[107,161],"i.v.":[111,166],"every":[113],"21-28":[114],"days)":[115],"produced":[116],"an":[117],"overall":[118],"rate":[120],"20%":[122],"(1":[123],"CR,":[124,179,195],"5":[125],"PRs).":[126],"Four":[127],"responding":[128,257],"were":[130],"resistant":[131],"previous":[133],"Median":[136],"survival":[137],"responders":[139],"was":[140],"27":[141,187,247],"months,":[142],"6":[144,206],"months":[145,207],"nonresponders":[147],"(P":[148],"=":[149],"0.0001).":[150],"Gynecologic":[152],"Group":[154],"confirmed":[155],"activity":[157],"(175":[160],"continuous":[164],"infusion)":[167],"41":[169],"cisplatin-resistant":[171],"patients,":[172],"whom":[174],"15":[175],"(37%)":[176],"responded":[177,193],"(5":[178],"10":[180],"PR).":[181,197],"A":[182],"total":[183],"8":[185],"(29%)":[188],"cisplatin-refractory":[191],"disease":[192,202],"(2/27":[194],"6/27":[196],"14":[199],"whose":[201],"progressed":[203],"more":[204,228],"than":[205,229],"following":[208],"therapy,":[210],"3":[211],"CRs":[213,248],"4":[215],"PRs.":[217],"Finally,":[218],"National":[220],"Institute":[222],"Treatment":[223],"Referral":[224],"Center":[225],"protocol":[226],"enrolled":[227],"2,000":[230],"patients;":[231],"preliminary":[232],"analysis":[233],"1,000":[235],"included":[237],"663":[238],"measurable":[243],"disease.":[244],"There":[245],"are":[246],"119":[250],"PRs;":[251],"median":[252],"time":[253],"progression":[255],"is":[259],"7":[260],"months.(ABSTRACT":[261],"TRUNCATED":[262],"AT":[263],"WORDS)":[265]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}